Cite
MLA Citation
L. Pascal et al.. “Stereotactic ablative radiotherapy (SABR) for early stage, non-small cell lung cancer (NSCLC): two year clinical outcome data from the Oxford Cancer Centre (OCC).” Lung cancer, vol. 139, n.d., pp. S33–. http://access.bl.uk/ark:/81055/vdc_100099353859.0x000048